Cardiac rehabilitation program for elderly patients with heart failure
Effectiveness of a Cardiac Rehabilitation Program on Biomechanical, Imaging, and Physiological Biomarkers in Elderly Patients With Heart Failure.
This study tests a cardiac rehabilitation program to see if it can help older adults with heart failure feel and function better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 126 (estimated) |
| Ages | 70 Years and up |
| Sex | All |
| Sponsor | University of Malaga Academic / other |
| Locations | 1 site (Málaga) |
| Trial ID | NCT05393362 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a cardiac rehabilitation program aimed at improving functionality in elderly patients diagnosed with heart failure. It employs kinematic analysis, cardiorespiratory capacity assessments, and measures of ventricular ejection fraction to gauge improvements. The study also seeks to validate kinematic analysis as a tool for functional assessment and to develop a functional index incorporating various biomarkers. By identifying responders to the rehabilitation program, the study aims to enhance personalized treatment approaches for this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are elderly individuals over 70 years old diagnosed with heart failure who are clinically stable and capable of participating in functional assessments.
Not a fit: Patients with severe cardiac conditions, significant cognitive impairment, or those unable to perform basic mobility tasks may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the physical functionality and quality of life for elderly patients suffering from heart failure.
How similar studies have performed: Previous studies have shown positive outcomes with cardiac rehabilitation programs in similar populations, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects older than 70 years. * Subjects diagnosed with Heart Failure (HF) followed by the Heart Failure Unit. * Subjects will be able or filling out questionnaires and perform functional tasks; * Clinical stability. * Patients receive optimal treatment. Exclusion Criteria: * Participants with cardiac pathologies that do not have an HF situation * Score on the NYHA scale equal to 4. * Hospitalization in a period of time equal to or less than 3 months. * Score on the Mini-Mental scale (MMSE) below 24. * Inability to get up from the chair at least 5 times * Inability to walk. * Inability to walk independently without a gait assist device (cane, crutch, or walker). * Participation in an experimental study where they receive treatment. * Inability to provide informed consent.
Where this trial is running
Málaga
- Antonio Cuesta Vargas — Málaga, Spain (Recruiting)
Study contacts
- Principal investigator: Cuesta Vargas A Antonio Ignacio, PhD — University of Malaga
- Study coordinator: Cuesta Vargas A Antonio Ignacio, PhD
- Email: acuesta@uma.es
- Phone: 952137551
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.